Bristol-Myers Squibb Company:企業のM&A・事業提携・投資動向

◆英語タイトル:Bristol-Myers Squibb Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2046
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:315
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Bristol-Myers Squibb Company – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Bristol-Myers Squibb Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Bristol-Myers Squibb Company since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Bristol-Myers Squibb Company’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Bristol-Myers Squibb Company. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Bristol-Myers Squibb Company’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Bristol-Myers Squibb Company and its subsidiaries since 2007.
- Information about key financial and legal advisors for Bristol-Myers Squibb Company’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Bristol-Myers Squibb Company’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 15
Corporate Venturing – Overview 15
Corporate Venturing – Deal reports 16
PARTNERSHIP 92
Partnership – Overview 92
Partnership – Deal reports 93
DIVESTMENTS 298
Divestments – Overview 298
Divestments – Deal reports 299
APPENDIX 305
Contact Us 305
About MarketLine Financial Deals Database 305
Deal Definition and Methodology 307
About MarketLine 314

List of Tables
Table 1: Bristol-Myers Squibb Company M&A volume and value trend (2014-YTD2018)
Table 2: Bristol-Myers Squibb Company M&A activity by geography (2014-YTD2018)
Table 3: Bristol-Myers Squibb Company corporate venturing volume and value trend (2014-YTD2018)
Table 4: Bristol-Myers Squibb Company corporate venturing by geography (2014-YTD2018)
Table 5: Bristol-Myers Squibb Company partnership volume and value trend (2014-YTD2018)
Table 6: Bristol-Myers Squibb Company partnership trend by key deal type (2014-YTD2018)
Table 7: Bristol-Myers Squibb Company divestments volume and value trend (2014-YTD2018)

List of Figures
Figure 1: Bristol-Myers Squibb Company M&A volume and value trend (2014-YTD2018)
Figure 2: Bristol-Myers Squibb Company M&A activity by geography (2014-YTD2018)
Figure 3: Bristol-Myers Squibb Company corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Bristol-Myers Squibb Company corporate venturing by geography (2014-YTD2018)
Figure 5: Bristol-Myers Squibb Company partnership volume and value trend (2014-YTD2018)
Figure 6: Bristol-Myers Squibb Company partnership trend by key deal type (2014-YTD2018)
Figure 7: Bristol-Myers Squibb Company divestments volume and value trend (2014-YTD2018)

★海外企業調査レポート[Bristol-Myers Squibb Company:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gene Techno Science Co Ltd (4584)-製薬・医療分野:企業M&A・提携分析
    Summary Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for cancer, intractable diseases and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-001 for immunological disease and oncology; GND-004, f …
  • Pinnacle Biologics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia Healthcare Corp. is a drug company that develops and markets photodynamic therapy products. The company offers products such as PHOTOFRIN PI, OPTIGUIDE PI, ETHYOL PI and DIOMED products. Its OPTIGUIDE PI products comprise …
  • Second Genome Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Second Genome Inc (Second Genome), formerly PhyloTech Inc, is a clinical stage pharmaceutical company that provides microbial research and drug discovery services. The company’s pipeline products include SGM-1019, a small molecule inhibitor targeting tissue injury and inflammation; and SG-2- …
  • CWC Energy Services Corp (CWC):石油・ガス:M&Aディール及び事業提携情報
    Summary CWC Energy Services Corp (CWC), formerly CWC Well Services Corp, is an oilfield servicing company that provides drilling rigs, service rigs, coil tubing and well testing services in the Western Canadian Sedimentary Basin. The company operates through two divisions such as contract drilling a …
  • LIG Nex1 Co., Ltd.:企業の戦略・SWOT・財務情報
    LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • HRG Group, Inc. (HRG):企業の財務・戦略的SWOT分析
    HRG Group, Inc. (HRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oge Energy Corp:企業の戦略・SWOT・財務分析
    Oge Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Oge Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Yokogawa Electric Corporation:戦略・SWOT・企業財務分析
    Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sorgenia SpA:電力:M&Aディール及び事業提携情報
    Summary Sorgenia SpA (Sorgenia) is an electricity generator and energy utilities company. The company operates in the energy and natural gas sector. It produces, imports, and sells electricity and gas. The company also offers various integrated power saving equipment and services. Sorgenia is a grou …
  • Vale Canada Ltd:企業の戦略・SWOT・財務分析
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Calfrac Well Services Ltd. (CFW)-石油・ガス分野:企業M&A・提携分析
    Summary Calfrac Well Services Ltd. (Calfrac) is an oilfield services company. It operates as an independent provider of specialized oilfield services. The company offers various specialized services such as hydraulic fracture-stimulation, coiled tubing, well simulation, fracturing, acidizing, frac d …
  • TransMontaigne Partners LP (TLP):企業の財務・戦略的SWOT分析
    Summary TransMontaigne Partners LP (TLP), a subsidiary of TransMontaigne GP LLC is an energy infrastructure service provider that offers integrated terminaling, transportation, and storage services. The company distributes and transports crude oil, chemicals, petroleum products, fertilizers, and oth …
  • Conatus Pharmaceuticals Inc (CNAT):製薬・医療:M&Aディール及び事業提携情報
    Summary Conatus Pharmaceuticals Inc (Conatus) is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the act …
  • Banco di Desio e della Brianza SpA:企業の戦略・SWOT・財務分析
    Banco di Desio e della Brianza SpA - Strategy, SWOT and Corporate Finance Report Summary Banco di Desio e della Brianza SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company offers its pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that …
  • FEMSA Comercio, S.A. de C.V.:企業の戦略・SWOT・財務情報
    FEMSA Comercio, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary FEMSA Comercio, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422)-製薬・医療分野:企業M&A・提携分析
    Summary Sichuan Kelun Pharmaceutical Co Ltd (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The company’s products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’ …
  • QEP Resources, Inc.:企業の戦略・SWOT・財務分析
    QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆